A Prospective Randomised Controlled Trial of Iron Supplementation in Patients Scheduled for Colorectal Cancer Surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN61221573

Enrollment

Registered

2005-09-30

Start date

2001-07-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer: Colorectal Cancer Malignant neoplasm of colon, malignant neoplasm of rectum

Interventions

All patients seen in the outpatient clinic and scheduled for colorectal cancer surgery will be recruited. Patients will be randomised to receive iron supplements or nothing until 3 days prior to admi

Eligibility

Inclusion criteria

Inclusion criteria: All patients seen in clinic with a diagnosis of colorectal cancer and fit for surgery will be eligible.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
To determine whether giving iron supplements to patients at the time of diagnosis of colorectal cancer increases, or prevents the decrease, in their haemoglobin levels, and reduces allogeneic blood exposure.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026